Engineered nanomaterial exposure and the risk of allergic disease

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 2, 2014, Pages 95-99

  Shannahan, Jonathan H ^a   Brown, Jared M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

dendritic cell; immunoglobulin E; mast cell; nanoparticle; T cell

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ALLERGIC DISEASE; CELL INTERACTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MAST CELL; NANOMEDICINE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE;

ANIMALS; BIOENGINEERING; DRUG HYPERSENSITIVITY; HUMANS; LEUKOCYTES; NANOSTRUCTURES;

EID: 84896725471     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000031     Document Type: Review

References (32)

1. Lu M, Cohen MH, Rieves D, Pazdur R. FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 2010; 85:315-319.
2. Shima F, Uto T, Akagi T, et al. Size effect of amphiphilic poly(gamma-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. Acta Biomater 2013; 9:8894-8901.
3. Toki S, Omary RA, Wilson K, et al. A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells. Nanomedicine 2013; 9:1235-1244.
4. Hirai T, Yoshikawa T, Nabeshi H, et al. Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol 2012; 9:3.
5. Park EJ, Bae E, Yi J, et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 2010; 30:162-168.
6. Chen EY, Garnica M, Wang YC, et al. A mixture of anatase and rutile TiO(2) nanoparticles induces histamine secretion in mast cells. Part Fibre Toxicol 2012; 9:2.
7. Wingard CJ, Walters DM, Cathey BL, et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 2011; 5:531-545.
8. Ekkapongpisit M, Giovia A, Nicotra G, et al. Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles. Int J Nanomedicine 2012; 7:1829-1840.
9. Huang YF, Liu H, Xiong X, et al. Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells. J Am Chem Soc 2009; 131:17328-17334.
10. Yang W, Lee S, Lee J, et al. Silver nanoparticle-induced degranulation observed with quantitative phase microscopy. J Biomed Opt 2010; 15:045005.
11. Maurer-Jones MA, Lin YS, Haynes CL. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 2010; 4:3363-3373.
12. Yamaki K, Yoshino S. Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation. Biometals 2009; 22:1031-1040.
13. Ryan JJ, Bateman HR, Stover A, et al. Fullerene nanomaterials inhibit the allergic response. J Immunol 2007; 179:665-672.
14. Voehringer D. Regulation of type 2 immunity by basophils. Adv Exp Med Biol 2013; 785:37-41.
15. Norton SK, Dellinger A, Zhou Z, et al. A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release. Clin Transl Sci 2010; 3:158-169.
16. Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 2012; 135:327-336.
17. Cruz LJ, Tacken PJ, Rueda F, et al. Targeting nanoparticles to dendritic cells for immunotherapy. Methods Enzymol 2012; 509:143-163.
18. Kunda NK, Somavarapu S, Gordon SB, et al. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm Res 2013; 30:325-341.
19. Raghuwanshi D, Mishra V, Suresh MR, Kaur K. A simple approach for enhanced immune response using engineered dendritic cell targeted nano-particles. Vaccine 2012; 30:7292-7299.
20. Almeida JP, Lin AY, Langsner RJ, et al. In vivo immune cell distribution of gold nanoparticles in naive and tumor bearing mice. Small 2013. doi: 10.1002/smll.201301998. [Epub ahead of print]
21. Zhang LW, Baumer W, Monteiro-Riviere NA. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (Lond) 2011; 6:777-791.
22. Laverny G, Casset A, Purohit A, et al. Immunomodulatory properties of multiwalled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. Toxicol Lett 2013; 217:91-101.
23. Schanen BC, Das S, Reilly CM, et al. Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles. PLoS ONE 2013; 8:e62816.
24. Shahbazi MA, Hamidi M, Makila EM, et al. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. Biomaterials 2013; 34:7776-7789.
25. Jiang H, Liu F, Yang H, Li Y. Effects of cobalt nanoparticles on human T cells in vitro. Biol Trace Elem Res 2012; 146:23-29.
26. Wang X, Podila R, Shannahan JH, et al. Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int J Nanomedicine 2013; 8:1733-1748.
27. Murray AR, Kisin ER, Tkach AV, et al. Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Part Fibre Toxicol 2012; 9:10.
28. Ding F, Radic S, Chen R, et al. Direct observation of a single nanoparticle-ubiquitin corona formation. Nanoscale 2013; 5:9162-9169.
29. Podila R, Chen R, Ke PC, et al. Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett 2012; 101:263701-L 263704.
30. Nygaard UC, Samuelsen M, Marioara CD, Lovik M. Carbon nanofibers have IgE adjuvant capacity but are less potent than nanotubes in promoting allergic airway responses. Biomed Res Int 2013; 2013:476010.
31. Brandenberger C, Rowley NL, Jackson-Humbles DN, et al. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. Part Fibre Toxicol 2013; 10:26.
32. Xu Y, Tang H, Liu JH, et al. Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. Toxicol Lett 2013; 219:42-48.